scispace - formally typeset
M

Mark P. Nicol

Researcher at University of Western Australia

Publications -  255
Citations -  15745

Mark P. Nicol is an academic researcher from University of Western Australia. The author has contributed to research in topics: Tuberculosis & Medicine. The author has an hindex of 54, co-authored 224 publications receiving 12945 citations. Previous affiliations of Mark P. Nicol include Boston Children's Hospital & University of Cape Town.

Papers
More filters
Journal ArticleDOI

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

Ting Shi, +138 more
- 02 Sep 2017 - 
TL;DR: In this paper, the authors estimated the incidence and hospital admission rate of RSV-associated acute lower respiratory infection (RSV-ALRI) in children younger than 5 years stratified by age and World Bank income regions.
Journal ArticleDOI

Variable host-pathogen compatibility in Mycobacterium tuberculosis.

TL;DR: It is demonstrated that the global population structure of M. tuberculosis is defined by six phylogeographical lineages, each associated with specific, sympatric human populations, and in an urban cosmopolitan environment, mycobacterial lineages were much more likely to spread in sympatrics than in allopatric patient populations.
Journal ArticleDOI

Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance

TL;DR: The Xpert(®) MTB/RIF assay is a rapid molecular assay that can be used close to the point of care by operators with minimal technical expertise, enabling diagnosis of TB and simultaneous assessment of rifampicin resistance to be completed within 2 h.